Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC
Authors
Keywords
-
Journal
International Journal of Nanomedicine
Volume Volume 15, Issue -, Pages 6451-6468
Publisher
Informa UK Limited
Online
2020-08-25
DOI
10.2147/ijn.s258906
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer
- (2019) Michael Shafique et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Silencing of Forkhead Box M1 Reverses Transforming Growth Factor-β1-Induced Invasion and Epithelial-Mesenchymal Transition of Endometriotic Epithelial Cells
- (2019) Jingjing Zhang et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Sodium new houttuyfonate suppresses metastasis in NSCLC cells through the Linc00668/miR-147a/slug axis
- (2019) Rilei Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The role of combination chemo-immunotherapy in advanced non-small cell lung cancer
- (2019) Danilo Rocco et al. Expert Review of Anticancer Therapy
- Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer
- (2019) Yuanyuan Wang et al. International Journal of Nanomedicine
- Polypeptide Derivative of Metformin with the Combined Advantage of a Gene Carrier and Anticancer Activity
- (2019) Thiruganesh Ramasamy et al. ACS Biomaterials-Science & Engineering
- RPV‐modified Epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply
- (2019) Liang Kong et al. CANCER SCIENCE
- Apolipoprotein E Deficiency Aggravates Neuronal Injury by Enhancing Neuroinflammation via the JNK/c-Jun Pathway in the Early Phase of Experimental Subarachnoid Hemorrhage in Mice
- (2019) Yue Wu et al. Oxidative Medicine and Cellular Longevity
- Nanopurpurin-based photodynamic therapy destructs extracellular matrix against intractable tumor metastasis
- (2018) Di Zhang et al. BIOMATERIALS
- Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide
- (2018) Congcong Lin et al. DRUG DELIVERY
- Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
- (2018) Yoshiro Itatani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway
- (2018) Rongmu Xia et al. LIFE SCIENCES
- Assessment of programmed cell death ligand-1 expression by 4 diagnostic assays and its clinicopathological correlation in a large cohort of surgical resected non-small cell lung carcinoma
- (2018) Anthony W. H. Chan et al. MODERN PATHOLOGY
- A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
- (2018) T. Azad et al. Nature Communications
- MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K/Akt pathway
- (2018) Jun Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The effect of estrogen on diabetic wound healing is mediated through increasing the function of various bone marrow-derived progenitor cells
- (2018) Ying Zhuge et al. JOURNAL OF VASCULAR SURGERY
- Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures
- (2018) X. Xie et al. Nanoscale
- Hyaluronic Acid/Bone Substitute Complex Implanted on Chick Embryo Chorioallantoic Membrane Induces Osteoblastic Differentiation and Angiogenesis, but not Inflammation
- (2018) Laura Cirligeriu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy
- (2018) Lucas C. Adam et al. Journal for ImmunoTherapy of Cancer
- Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review
- (2017) Thiruganesh Ramasamy et al. JOURNAL OF CONTROLLED RELEASE
- HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment
- (2017) Meili Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment
- (2017) Binlong Chen et al. Theranostics
- Targeting Angiogenesis in Advanced Non-Small Cell Lung Cancer
- (2017) Philip E. Lammers et al. Journal of the National Comprehensive Cancer Network
- An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic Cancer
- (2016) Tianjiao Ji et al. ACS Applied Materials & Interfaces
- A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA
- (2016) Cong Luo et al. BIOMATERIALS
- Analysis of caveolin-1 and phosphoinositol-3 kinase expression in primary uveal melanomas
- (2016) Miriam Stenzel et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype
- (2016) Lingli Yao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A Novel Strategy through Combining iRGD Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration
- (2015) Xingli Cun et al. ACS Applied Materials & Interfaces
- Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer
- (2015) Guangmei Mao et al. ANGIOGENESIS
- MMP-2 responsive polymeric micelles for cancer-targeted intracellular drug delivery
- (2015) Wei-Hai Chen et al. CHEMICAL COMMUNICATIONS
- Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo
- (2015) Junjie Liu et al. Nanoscale
- Liposomes, modified with PTDHIV-1 peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer
- (2014) Rui-Jun Ju et al. BIOMATERIALS
- Nanoscaled Poly(l-glutamic acid)/Doxorubicin-Amphiphile Complex as pH-responsive Drug Delivery System for Effective Treatment of Nonsmall Cell Lung Cancer
- (2013) Mingqiang Li et al. ACS Applied Materials & Interfaces
- Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity
- (2013) Yu Wan et al. BIOMATERIALS
- Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma
- (2013) Shuhei Yoshida et al. HEPATOLOGY
- A novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes
- (2013) Shinji Takeoka et al. International Journal of Nanomedicine
- Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety
- (2013) L. Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Matrix Metalloprotease 2-Responsive Multifunctional Liposomal Nanocarrier for Enhanced Tumor Targeting
- (2012) Lin Zhu et al. ACS Nano
- Ultrasound Increases Nanoparticle Delivery by Reducing Intratumoral Pressure and Increasing Transport in Epithelial and Epithelial-Mesenchymal Transition Tumors
- (2012) K. D. Watson et al. CANCER RESEARCH
- Cell-penetrating peptides: breaking through to the other side
- (2012) Erez Koren et al. TRENDS IN MOLECULAR MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started